Congenital anomalies after first-trimester dydrogesterone therapy during in vitro fertilization.

We acknowledge the concern that, given the large number of subgroup comparisons and the very small event counts in most anomaly categories, the few nominally significant P-values in Tables 3 and 4 should be interpreted with caution.

also in 7,732 other papers